The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 13, 2018
Filed:
Aug. 04, 2017
Applicant:
Plexxikon Inc., Berkeley, CA (US);
Inventors:
Gideon Bollag, Hercules, CA (US);
Klaus-Peter Hirth, San Francisco, CA (US);
Prabha N. Ibrahim, Mountain View, CA (US);
Paul Lin, Oakland, CA (US);
Brian West, San Francisco, CA (US);
Assignee:
Plexxikon Inc., Berkeley, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/444 (2006.01); A61K 31/357 (2006.01); A61K 31/436 (2006.01); A61K 31/437 (2006.01); A61K 31/4545 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/444 (2013.01); A61K 9/0053 (2013.01); A61K 31/357 (2013.01); A61K 31/436 (2013.01); A61K 31/437 (2013.01); A61K 31/4545 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 471/04 (2013.01); A61K 2300/00 (2013.01);
Abstract
The present disclosure provides methods of using protein kinase inhibitors for treating diseases and conditions, including diseases and conditions associated with activity of any protein kinase selected from Fms protein kinase including any mutations thereof, Kit protein kinase any mutations thereof, Flt-3 protein kinase any mutations thereof and combinations thereof.